Schrodinger recovers rights to cancer drug candidate from Bristol
koto_feja Bristol-Myers Squibb (New York Stock Exchange:BMY) has returned the rights to a preclinical cancer drug candidate, an SOS1 inhibitor, ...
Tag: Drug
Weight-loss drug prompts Eli Lilly to raise 2024 sales forecast by $2 billion By Reuters
By Bhanvi Satija and Patrick Wingrove(Reuters) -Explosive demand and increased manufacturing capacity for Eli Lilly's (NYSE:) weight-loss drug Zepbound led ...
Scale AI training and inference for drug discovery through Amazon EKS and Karpenter
This is a guest post co-written with the leadership team of Iambic Therapeutics. ai/" target="_blank" rel="noopener">Iambic Therapeutics is a drug ...
How to advance in data science. My advice and experience to become a drug addict… | by Egor Howell | March 2024
Photo by David Gavi in unpackAn idea popularized by the book Atomic Habits (by James Clear) is that improving 1% ...
Use RAG for drug discovery with Knowledge Bases for Amazon Bedrock
Amazon Bedrock provides a broad range of models from Amazon and third-party providers, including Anthropic, AI21, Meta, Cohere, and Stability ...
Ionis Angioedema Drug Shows Positive Results in Phase 3 Trial (NASDAQ:IONS)
Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...
MS drug developer Kyverna Therapeutics files for $100 million IPO
Chunumunu Kyverna Therapeutics (KYTX), which is developing therapies for autoimmune disorders such as lupus and multiple sclerosis, has filed a ...
First injections of RSV and gene editing drug among the drugs of 2024 to take into account
Khanchit Khirisutchalual/iStock via Getty Images Some of the pioneering medical advances in recent history, including the first RSV vaccines and ...
Shattuck Labs Stock Jumps 90% on Phase 1 Data for Blood Cancer Drug (STTK)
Md Babul Hosen/iStock via Getty Images Shattuck Laboratories (NASDAQ: STTK) shares soared 90% in morning trading Wednesday after the biotech ...
Citi is bullish on Biomea amid sell-off, says market misinterprets drug data (BMEA)
Sir Citi bank on Friday urged investors to "buy the big dip" in Biomea Fusion (NASDAQ:BMEA) stock, arguing that the ...
Recommended.
